Brachytherapy
Volume 8, Issue 3 , Pages 284-289 , July 2009

Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy

  • Laval Grimard

      Affiliations

    • Department of Radiation Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, The Ottawa Hospital Regional Cancer Centre, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6. Tel.: +1-613-737-7700 ext. 70194; fax: +1-613-247-3511.
    • ,
  • Bernd Esche

      Affiliations

    • Department of Radiation Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
    • ,
  • André Lamothe

      Affiliations

    • Department of Otolaryngology, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada
    • ,
  • Johanna N. Spaans

      Affiliations

    • Cancer Therapeutics, Ottawa Health Research Institute, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

Received 30 March 2008 ,Revised 29 December 2008 ,Accepted 30 December 2008.

References 

  1. American Cancer Society, Surveillance Research, Facts & Figures, 2004.
  2. Garg M, Beitler JJ. Controversies in management of the neck in head and neck cancer. Curr Treat Options Oncol. 2004;5:35–40
  3. Fu KK, Pajak TF, Trotti A, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7–16
  4. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991;324:1685–1690
  5. Looser KG, Shah JP, Strong EW. The significance of “positive” margins in surgically resected epidermoid carcinoma. Head Neck Surg. 1978;1:107–111
  6. Barkley HT, Fletcher GH. The significance of residual disease after external irradiation of squamous cell carcinoma of the oropharynx. Radiology. 1977;124:493–495
  7. Katsuno S, Takemae T, Ishiyam T, et al. Is carotid reconstruction for advanced cancer in the neck a safe procedure?. Otolaryngology. 2001;124:222–224
  8. Freeman SB, Hamaker RC, Borrowdale RB, et al. Management of neck metastasis with carotid artery involvement. Laryngoscope. 2004;114:20–24
  9. Choy D, Sham JST, Wei WI, et al. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1993;25:505–512
  10. Sham JST, Wei WI, Choy D, et al. Treatment of persistent and recurrent nasopharyngeal carcinoma by brachytherapy. Br J Radiol. 1989;62:355–361
  11. Glatzel M, Buntzel J, Schoder D, et al. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck disease. Laryngoscope. 2002;112:1366–1371
  12. Chua DT, Wei WI, Sham JS, et al. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma. Head Neck. 2003;25:585–594
  13. Syed AM, Puthawala AA, Damore SJ, et al. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial. Int J Radiat Oncol Biol Phys. 2000;47:1311–1321
  14. Grimard L, Esche B, Lamothe A, et al. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies. Head Neck. 2006;28:888–895
  15. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163–170
  17. Cox DR. Regression models and life tables. J R Stat Soc Ser. 1972;34B:187–202
  18. Farias TP, Dias FL, Lima RA, et al. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:794–799
  19. Marcial VA, Hanley JA, Chang C, et al. Split-course radiation therapy of carcinoma of the nasopharynx: Results of a national collaborative clinical trial of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980;6:409–414
  20. Heng DM, Wee J, Fong KW, et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer. 1999;86:1912–1920
  21. Kwong DL, Nicholls J, Wei WI, et al. The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma. Cancer. 1999;85:1446–1453
  22. Kaylie DM, Stevens KR, Kang MY, et al. External beam radiation followed by planned neck dissection and brachytherapy for base of tongue squamous cell carcinoma. Laryngoscope. 2000;110:1633–1636
  23. Narayana A, Cohen GN, Zaider M, et al. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers—Preliminary results. Brachytherapy. 2007;6:157–163
  24. Yau TK, Sze WM, Lee WM, et al. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma. Head Neck. 2004;26:1024–1030

 None of the authors have a financial interest, arrangement, or affiliation with a commercial organization that may have a direct or indirect interest in the subject matter of this article.

PII: S1538-4721(09)00195-0

doi: 10.1016/j.brachy.2008.12.007

Brachytherapy
Volume 8, Issue 3 , Pages 284-289 , July 2009

Article Tools

* Image Usage & Resolution